INTERVIEW · HEALTH · Caring Cross · Milken Global Conference 2025 · 8:28 · Released September 30, 2026
"Only 25% of eligible patients get CAR-T therapy. In low-income countries it's under 1%." - Milken Global 2025
Nonprofit Caring Cross on making curative cell and gene therapies affordable: teaching hospitals in Brazil, the UAE and Nigeria to manufacture CAR-T cells locally at a tenth of the US cost, and why a $3 million cure helps nobody who can’t reach it.
HealthcareScience
Up next
More like this5:02
What's the Future of the Brain?
Healthcare
4:37
What's the Future of Longevity?
Healthcare
11:55
In Many Health Centres There Is Nobody to Ask | Samsung Healthcare | Healthcare AI
RSNA 2025
11:19
Technology, Cloud and the Future, GCC Conclave 2019
Ian Khan · GCC Conclave 2019
3:43
Reducing the Friction Between Government and People | Ian Khan at WGS 2024
Government Experience
9:26
Applying 'Never Events' Thinking to Clinical AI | Dr Erin Palm, Infinitus
ViVE 2026
11:08
Personalisation Does Not Matter Equally to Every Brand - Possible 2025
POSSIBLE Miami 2025
9:04
It Is Impossible to Debank Someone | Dom Kwok, EasyA
Consensus 2025 Toronto
11:43
A Billion Women Still Lack a Bank Account | Mary Ellen Iskenderian, Women's World Banking
Mary Ellen Iskenderian, Women's World Banking · Money20/20 USA 2026
10:45
AI Agents That Join the Fraud Team | Roy Zur, Charm Security
Roy Zur, Charm Security · Money20/20 USA 2026